Spinal Anesthesia With Articaine and Lidocaine for Outpatient Surgery.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00247741
Recruitment Status : Completed
First Posted : November 2, 2005
Last Update Posted : December 19, 2013
Information provided by:
St. Antonius Hospital

November 1, 2005
November 2, 2005
December 19, 2013
November 2005
Not Provided
  • Onset time (sec) of sensory and motor blockade (after administration of drug)
  • Recovery time (min) from sensory and motor blockade
  • Spread of sensory blockade (30 min after administration of drug, dermatomal level)
Same as current
Complete list of historical versions of study NCT00247741 on Archive Site
  • Hemodynamic stability (lowest systolic blood pressure, vasopressor therapy)
  • Complications
  • Patient satisfaction
Same as current
Not Provided
Not Provided
Spinal Anesthesia With Articaine and Lidocaine for Outpatient Surgery.
Spinal Anesthesia With Articaine and Lidocaine for Outpatient Surgery: A Double Blind Randomized Clinical Trial.
The purpose of this study is to compare two short-acting local anesthetics, articaine and lidocaine, for spinal anesthesia in day-case surgery. The onset time of the sensory- and motor block, recovery time until discharge and complications will be studied.

The ideal spinal anesthesia in day-case surgery is characterized by a short onset of sensory and motor blockade, and a rapid recovery after the operation. Short-acting local-anesthetics are used frequently in this setting.

Lidocaine is one of the agents that is used most frequently. It has been associated with an increased incidence of Transient Neurological Symptoms (TNS). Articaine is another agent that is being used more often and is said to act faster and shorter than lidocaine.

We will compare spinal anesthesia with lidocaine and articaine in a randomized double-blind clinical trial. Endpoint are:

  • onset of sensory and motor block
  • recovery from sensory and motor block
  • time to micturition
  • patient satisfaction
  • complications
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Spinal Anesthesia
  • Drug: spinal administration of articaine
  • Drug: spinal administration of lidocaine
  • Active Comparator: lidocaine
    Intervention: Drug: spinal administration of lidocaine
  • Experimental: articaine
    Intervention: Drug: spinal administration of articaine

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Same as current
May 2006
Not Provided

Inclusion Criteria:

  • Age > 18 years
  • Patients planned for a short surgical procedure on lower extremities or lower abdomen.
  • Procedure in day-case setting
  • Procedure under spinal anesthesia
  • Informed consent

Exclusion Criteria:

  • Contra-indications spinal anesthesia
  • History of allergic reactions on amide-type local anesthetics
  • Pregnancy
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
St. Antonius Hospital
Not Provided
Principal Investigator: Leon Timmerman, MD St Antonius Hospital, dept. of anesthesiology
Study Chair: Emile MJ Andriessen, MD St Antonius Hospital, dept of anesthesiology
St. Antonius Hospital
October 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP